![Half of Public Has Heard Little or Nothing About the New COVID-19 Booster Aimed at Omicron; Many Don't Know If the CDC Recommends That They Get the New Booster | KFF Half of Public Has Heard Little or Nothing About the New COVID-19 Booster Aimed at Omicron; Many Don't Know If the CDC Recommends That They Get the New Booster | KFF](https://www.kff.org/wp-content/uploads/2022/09/Fig-3-a-third-of-adults-have-gotten-or-will-get-updated-booster.png)
Half of Public Has Heard Little or Nothing About the New COVID-19 Booster Aimed at Omicron; Many Don't Know If the CDC Recommends That They Get the New Booster | KFF
![CDC recommends new COVID booster for all Americans over 6 months amid rising cases, hospitalizations - ABC News CDC recommends new COVID booster for all Americans over 6 months amid rising cases, hospitalizations - ABC News](https://i.abcnewsfe.com/a/8751bb25-b566-4440-9e9c-72099e9696bf/covid-2-rt-bb-230906_1694012668027_hpEmbed_3x2.jpg)
CDC recommends new COVID booster for all Americans over 6 months amid rising cases, hospitalizations - ABC News
![CDC on X: "The updated bivalent #COVID19 boosters help restore protection that has decreased since previous vaccination and provide broader protection against the newer BA.4 and BA.5 variants. To search for a CDC on X: "The updated bivalent #COVID19 boosters help restore protection that has decreased since previous vaccination and provide broader protection against the newer BA.4 and BA.5 variants. To search for a](https://pbs.twimg.com/media/FcuZrNrXoAUhCHQ.jpg)
CDC on X: "The updated bivalent #COVID19 boosters help restore protection that has decreased since previous vaccination and provide broader protection against the newer BA.4 and BA.5 variants. To search for a
![Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection — Increasing Community Access to Testing Program, United States, September–November 2022 | MMWR Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection — Increasing Community Access to Testing Program, United States, September–November 2022 | MMWR](https://www.cdc.gov/mmwr/volumes/71/wr/social-media/mm7148e1-BivalentBooster_IMAGE_22NOV2022_1200x675.jpg?_=65732)
Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection — Increasing Community Access to Testing Program, United States, September–November 2022 | MMWR
![Updated Toolkit: COVID-19 Booster Dose Messaging and Outreach Tools - Public Health Communications Collaborative (PHCC) Updated Toolkit: COVID-19 Booster Dose Messaging and Outreach Tools - Public Health Communications Collaborative (PHCC)](https://publichealthcollaborative.org/wp-content/uploads/2022/10/ENG_Twitter_updated-booster-doses-2.png)